Abnormalities in the number and function of CD4+ T cell subsets, including Th1 cells (2, 3), Th17 cells (4, 5), and regulatory T cells (Tregs) (6, 7), occur in the peripheral blood and lungs of patients with COPD, possibly influencing and perpetuating chronic inflammation. Here, CD4 is linked to chronic obstructive pulmonary disease.